Short Interest in Semler Scientific, Inc. (NASDAQ:SMLR) Rises By 43.4%

Semler Scientific, Inc. (NASDAQ:SMLR) was the recipient of a significant increase in short interest during the month of November. As of November 30th, there was short interest totalling 1,280,000 shares, an increase of 43.4% from the November 15th total of 892,400 shares. Approximately 20.4% of the company’s stock are sold short. Based on an average daily volume of 485,000 shares, the short-interest ratio is currently 2.6 days.

Hedge Funds Weigh In On Semler Scientific

Several institutional investors have recently bought and sold shares of SMLR. Principal Financial Group Inc. bought a new position in shares of Semler Scientific in the third quarter valued at approximately $361,000. Verition Fund Management LLC bought a new position in Semler Scientific in the 3rd quarter worth $251,000. Shariaportfolio Inc. acquired a new position in Semler Scientific during the 3rd quarter worth $3,618,000. CWM LLC lifted its position in Semler Scientific by 486.3% during the 2nd quarter. CWM LLC now owns 897 shares of the company’s stock worth $31,000 after acquiring an additional 744 shares during the last quarter. Finally, Cerity Partners LLC boosted its holdings in Semler Scientific by 91.5% during the third quarter. Cerity Partners LLC now owns 1,345,586 shares of the company’s stock valued at $31,689,000 after acquiring an additional 642,982 shares during the period. 49.37% of the stock is currently owned by institutional investors.

Semler Scientific Price Performance

NASDAQ:SMLR traded down $4.67 during mid-day trading on Friday, reaching $67.17. The stock had a trading volume of 971,401 shares, compared to its average volume of 1,077,116. The stock has a market cap of $556.84 million, a P/E ratio of 32.77 and a beta of 1.18. The business’s 50 day moving average is $43.82 and its 200 day moving average is $34.81. Semler Scientific has a fifty-two week low of $20.88 and a fifty-two week high of $79.45.

Semler Scientific (NASDAQ:SMLR) last announced its quarterly earnings results on Monday, November 4th. The company reported $0.72 EPS for the quarter, topping the consensus estimate of $0.37 by $0.35. The company had revenue of $13.51 million for the quarter. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.